A new study in mice suggests that replacing a dysfunctional gene may extend survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart gradually weaken, putting patients at risk of dangerous irregula